IQVIA’s LAAD Plus integrates open and closed claims data to deliver a more complete view of patient journeys, providers, and treatment outcomes. For a pharma company in rare disease, the solution combined LAAD’s pre-adjudicated claims with PharMetrics Plus’ adjudicated health plan claims. The pilot identified 15% more providers, 15% more patients, 10% more diagnoses, and 20% more procedures versus LAAD alone, revealing richer insights into treatment dynamics and reimbursement. It also captured cash payments and expanded detail on payer types. By merging datasets, LAAD Plus enhances provider targeting, market understanding, and commercial strategy refinement.

Join for free to read